{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/scarlet-fever/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"61377ddb-df7a-50fb-9dd7-224014332a4e","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 1382a08a-f4d1-4e72-a58d-a3e43a9c130d --><h2>Changes</h2><!-- end field 1382a08a-f4d1-4e72-a58d-a3e43a9c130d -->","summary":null,"htmlStringContent":"<!-- begin item abb34c80-607a-4492-8616-c10c2357ca13 --><!-- begin field 53208a93-1a78-4dc8-bfa7-934a21147fff --><p><strong>March 2020 </strong>— reviewed. A literature search was conducted in February 2020 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. The topic has undergone minor restructuring. A new section on Risk factors has been added to the Background information section. The section on Admission has been deleted and the content incorporated into the section on Management. Recommendations have been updated in line with current evidence. No major changes to the recommendations have been made.</p><!-- end field 53208a93-1a78-4dc8-bfa7-934a21147fff --><!-- end item abb34c80-607a-4492-8616-c10c2357ca13 -->","topic":{"id":"7c05f7c5-902d-5982-8cc9-5f1d301d214d","topicId":"f534013d-38dd-4f96-bc65-37091262952c","topicName":"Scarlet fever","slug":"scarlet-fever","lastRevised":"Last revised in March 2020","chapters":[{"id":"d3f6c278-a759-50f3-9a96-734913f439ab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ffff4a88-7ddf-55dc-a37b-1625f3f58e2b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"89be33c0-acbe-51fd-901b-d7cf571435a4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"61377ddb-df7a-50fb-9dd7-224014332a4e","slug":"changes","fullItemName":"Changes"},{"id":"b5e95aca-9003-52f8-b6e7-0c192c5ba757","slug":"update","fullItemName":"Update"}]},{"id":"90d2085f-63f5-57a1-b21e-21d4c580229a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cc3aa630-ef6b-5504-9439-6a4757e7fe43","slug":"goals","fullItemName":"Goals"},{"id":"ebf64432-58f2-513f-a393-ec4e8438f355","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b3da9abe-7cc8-5c97-970d-39b1416de8cb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8b3309e1-1d9f-520e-b310-592706c0951d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0603af50-edd7-5e78-a394-1fd6a1a1af21","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00da52ed-356a-563d-aa3c-dc4e3ee27155","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7072120a-72ec-5945-b4f0-e4386374e1ad","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f61354f7-80ff-5483-89fc-51be1d57b5d3","slug":"definition","fullItemName":"Definition"},{"id":"4dc22989-c1d3-5880-a381-78cabd38ca4d","slug":"transmission","fullItemName":"Transmission"},{"id":"c4e4e4ff-9b93-5d55-8ae0-5e0b1a518ef3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"5b31f083-75b7-5ae3-9029-87df9bc061cf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"94ffb885-96f6-595f-b1ad-fb146a27db30","slug":"complications","fullItemName":"Complications"},{"id":"f3bf38a0-7946-504a-b22c-654728a0366a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ffb84f0d-77eb-5011-a50d-14d9143e4bd4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8484304f-9507-5401-8c08-2c93126a8b3f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"601ddd63-7670-5740-a0f6-fe317e0d7770","slug":"investigations","fullItemName":"Investigations"},{"id":"a1df37ba-9251-52d5-8376-b19803e39cc3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5329e2f2-3618-5113-8fc1-5228ff864869","fullItemName":"Management","slug":"management","subChapters":[{"id":"963d805b-33a2-5e78-9195-323379519c7e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"db4a097c-9d97-5e1e-8718-e082e8e25f5e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4a26593a-c9e4-5523-a6d2-5feb274dcf79","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"},{"id":"2a494a84-0688-5337-8f03-a2ab33a654fb","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"ce256942-e7de-5014-bdf7-f34be5755538","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"7e3b4438-f437-5199-8ee5-f3c9d210b732","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f2446794-c34e-574f-8de3-c5ecbe3c4f35","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1a90ff7f-b2b6-5959-86a0-3cea6609706f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d14df6f-1299-58da-b620-c970e5b90b91","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"db42b54d-b095-52b7-9cb1-37d73c57fdb7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"551dac2a-e65d-57c4-b16c-279891510a2b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5d76e530-4218-5600-a9ed-896a3245aefb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"03221ed8-00f7-5819-b90c-cc69c4a1fdb8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"89be33c0-acbe-51fd-901b-d7cf571435a4","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"064756ec-3c4e-53cf-8194-1da3c1692f24","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field cc8edabe-6609-49c1-a149-a81f353cbddb --><h3>Previous changes</h3><!-- end field cc8edabe-6609-49c1-a149-a81f353cbddb -->","summary":null,"htmlStringContent":"<!-- begin item 33e09f1d-a7d8-49fb-8dfd-d9e167ca2be2 --><!-- begin field 33e952d7-32fd-4418-bc3c-ec2479199523 --><p><strong>June 2018 </strong>— minor update. Prescribing information updated with information regarding azithromycin interacting with colchicine.  </p><p><strong>September 2015 to October 2015</strong> — reviewed. A literature search was conducted in September 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. Changes to the recommendations are based on guidelines from Public Health England (PHE, 2015), and include the use of azithromycin instead of erythromycin as treatment for scarlet fever in people who are allergic to penicillin.</p><p><strong>July 2015</strong> — minor update. Statins have been included in the list of drugs metabolized by cytochrome P450 isoenzymes that interact with erythromycin and clarithromycin. </p><p><strong>May 2014</strong> — minor update. Links to prescriptions have been removed and replaced with text on the doses of antibiotics. </p><p><strong>February 2013</strong> — minor update. The 2013 QIPP options for local implementation have been added to this topic. </p><p><strong>October 2012</strong> — minor update. The 2012 QIPP options for local implementation have been added to this topic. </p><p><strong>July 2011</strong> — minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency (MHRA). Prescriptions have been updated to reflect the revised dosing. Issued in July 2011. </p><p><strong>May 2010</strong> — minor update to state that the Health Protection Agency should be notified following clinical diagnosis of scarlet fever. </p><p><strong>February to May 2010</strong> — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 33e952d7-32fd-4418-bc3c-ec2479199523 --><!-- end item 33e09f1d-a7d8-49fb-8dfd-d9e167ca2be2 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}